Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Piotroski F-Score
4 (As of Today)

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

GlaxoSmithKline PLC has an F-score of 4 indicating the company's financial situation is typical for a stable company.

GSK' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Max: 8
Current: 4

2
8

During the past 13 years, the highest Piotroski F-Score of GlaxoSmithKline PLC was 8. The lowest was 2. And the median was 6.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Mar16) TTM:Last Year (Mar15) TTM:
Net Income was 232.087227414 + 825.153374233 + -529.94011976 + 401.709401709 = $929 Mil.
Cash Flow from Operations was 338.00623053 + 737.73006135 + 2247.00598802 + 716.524216524 = $4,039 Mil.
Revenue was 9171.33956386 + 9397.2392638 + 9410.17964072 + 8873.21937322 = $36,852 Mil.
Gross Profit was 6048.28660436 + 6016.87116564 + 5606.28742515 + 5834.75783476 = $23,506 Mil.
Average Total Assets from the begining of this year (Mar15)
to the end of this year (Mar16) was
(86690.5829596 + 84295.9501558 + 81472.392638 + 80008.9820359 + 77605.4131054) / 5 = $82014.664179 Mil.
Total Assets at the begining of this year (Mar15) was $86,691 Mil.
Long-Term Debt was $22,434 Mil.
Total Current Assets was $22,548 Mil.
Total Current Liabilities was $19,828 Mil.
Net Income was 1106.59898477 + 653.094462541 + 1616.58841941 + 12091.180867 = $15,467 Mil.

Revenue was 9409.47546531 + 9195.43973941 + 9680.75117371 + 8403.58744395 = $36,689 Mil.
Gross Profit was 6495.76988156 + 6216.61237785 + 6505.47730829 + 5260.0896861 = $24,478 Mil.
Average Total Assets from the begining of last year (Mar14)
to the end of last year (Mar15) was
(65958.4717608 + 65736.0406091 + 65640.0651466 + 63616.5884194 + 86690.5829596) / 5 = $69528.3497791 Mil.
Total Assets at the begining of last year (Mar14) was $65,958 Mil.
Long-Term Debt was $22,752 Mil.
Total Current Assets was $31,187 Mil.
Total Current Liabilities was $23,596 Mil.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

GlaxoSmithKline PLC's current net income (TTM) was 929. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

GlaxoSmithKline PLC's current cash flow from operations (TTM) was 4,039. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income (TTM)/Total Assets at the Beginning of This Year (Mar15)
=929.009883596/86690.5829596
=0.01071639

ROA (Last Year)=Net Income (TTM)/Total Assets at the Beginning of Last Year (Mar14)
=15467.4627337/65958.4717608
=0.23450305

GlaxoSmithKline PLC's return on assets of this year was 0.01071639. GlaxoSmithKline PLC's return on assets of last year was 0.23450305. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

GlaxoSmithKline PLC's current net income (TTM) was 929. GlaxoSmithKline PLC's current cash flow from operations (TTM) was 4,039. ==> 4,039 > 929 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar16)=Long-Term Debt/Average Total Assets from Mar15 to Mar16
=22434.4729345/82014.664179
=0.27354222

Gearing (Last Year: Mar15)=Long-Term Debt/Average Total Assets from Mar14 to Mar15
=22751.8684604/69528.3497791
=0.32723153

GlaxoSmithKline PLC's gearing of this year was 0.27354222. GlaxoSmithKline PLC's gearing of last year was 0.32723153. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year: Mar16)=Total Current Assets/Total Current Liabilities
=22548.4330484/19827.6353276
=1.1372225

Current Ratio (Last Year: Mar15)=Total Current Assets/Total Current Liabilities
=31186.8460389/23596.4125561
=1.32167744

GlaxoSmithKline PLC's current ratio of this year was 1.1372225. GlaxoSmithKline PLC's current ratio of last year was 1.32167744. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

GlaxoSmithKline PLC's number of shares in issue this year was 2445. GlaxoSmithKline PLC's number of shares in issue last year was 2430.5. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=23506.2030299/36851.9778416
=0.63785458

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=24477.9492538/36689.2538224
=0.66716945

GlaxoSmithKline PLC's gross margin of this year was 0.63785458. GlaxoSmithKline PLC's gross margin of last year was 0.66716945. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year’s asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue (TTM)/Total Assets at the Beginning of This Year (Mar15)
=36851.9778416/86690.5829596
=0.42509782

Asset Turnover (Last Year)=Revenue (TTM)/Total Assets at the Beginning of Last Year (Mar14)
=36689.2538224/65958.4717608
=0.55624779

GlaxoSmithKline PLC's asset turnover of this year was 0.42509782. GlaxoSmithKline PLC's asset turnover of last year was 0.55624779. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

GlaxoSmithKline PLC has an F-score of 4 indicating the company's financial situation is typical for a stable company.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Question 1 1111111111
Question 2 1111111111
Question 3 1001010101
Question 4 0111110110
Question 5 1000110011
Question 6 1010000101
Question 7 1111011110
Question 8 1001010010
Question 9 1001010001
F-score 8457483666

GlaxoSmithKline PLC Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
Question 1 1111111111
Question 2 1111111111
Question 3 1111011110
Question 4 1111100001
Question 5 0111111111
Question 6 1010011110
Question 7 1011111000
Question 8 0000100000
Question 9 0000000010
F-score 6576666564
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK